Clinical Trial

Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer

Study acronym: CHOCA
Recruiting
View on ClinicalTrials.gov →
Summary
No validated biomarkers exist that can identify patients with biliary tract cancer at an early stage or predict treatment outcomes. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.
Trial Details
NCT Number NCT05184400
Lead Sponsor Herlev and Gentofte Hospital
Conditions Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer
Enrollment 500 participants
Start Date 2015-01-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-01-11